Lior Golomb
About Lior Golomb
Lior Golomb is a Research Fellow with a decade of experience at Dana-Farber Cancer Institute, Harvard Medical School, and Broad Institute, all since 2014. He holds a Ph.D. in Cellular and Molecular Biology from Weizmann Institute of Science and a Master's degree in Plant Molecular Biology from The Hebrew University.
Work at Broad Institute
Lior Golomb has been a Research Fellow at the Broad Institute since 2014. In this role, he engages in advanced research initiatives focused on cancer biology and genomics. The Broad Institute is known for its collaborative approach to biomedical research, and Golomb contributes to projects that aim to enhance understanding of cancer mechanisms and develop innovative therapeutic strategies.
Current Positions at Dana-Farber Cancer Institute and Harvard Medical School
Since 2014, Lior Golomb has also held positions as a Research Fellow at both Dana-Farber Cancer Institute and Harvard Medical School. These institutions are recognized for their contributions to cancer research and medical education. Golomb's work involves collaboration with leading scientists and participation in cutting-edge research projects that address critical questions in cancer treatment and prevention.
Education and Expertise
Lior Golomb earned a Bachelor's degree in Plant Sciences from The Hebrew University, completing his studies from 2002 to 2005. He then pursued a Master's degree in Plant Molecular Biology at the same institution from 2005 to 2007. Following this, he obtained a Doctor of Philosophy (Ph.D.) in Cell/Cellular and Molecular Biology from the Weizmann Institute of Science, where he studied from 2008 to 2013. This educational background provides a strong foundation for his research in molecular biology and cancer.
Academic Background
Lior Golomb's academic journey began at The Hebrew University, where he completed his Bachelor's degree in Plant Sciences. He furthered his studies with a Master's degree in Plant Molecular Biology at the same university. His pursuit of knowledge continued at the Weizmann Institute of Science, culminating in a Ph.D. in Cell/Cellular and Molecular Biology. This comprehensive academic experience has equipped him with a robust understanding of biological sciences.